The complex patient: a concept clarification E Manning, M Gagnon Nursing & health sciences 19 (1), 13-21, 2017 | 131 | 2017 |
Governing through (in) security: a critical analysis of a fear-based public health campaign M Gagnon, JD Jacob, D Holmes Critical public health 20 (2), 245-256, 2010 | 128 | 2010 |
Locating the qualitative interview: reflecting on space and place in nursing research M Gagnon, JD Jacob, J McCabe Journal of Research in Nursing 20 (3), 203-215, 2015 | 108 | 2015 |
Re-thinking HIV-related stigma in health care settings: A qualitative study M Gagnon Journal of the Association of Nurses in AIDS Care 26 (6), 703-719, 2015 | 83 | 2015 |
Nursing so-called monsters: On the importance of abjection and fear in forensic psychiatric nursing JD Jacob, M Gagnon, D Holmes Journal of Forensic nursing 5 (3), 153-161, 2009 | 78 | 2009 |
Working in a ‘third space’: a closer look at the hybridity, identity and agency of nurse practitioners T Chulach, M Gagnon Nursing inquiry 23 (1), 52-63, 2016 | 75 | 2016 |
Working with patients living with obesity in the intensive care unit: a study of nurses' experiences JM Shea, M Gagnon Advances in Nursing Science 38 (3), E17-E37, 2015 | 54 | 2015 |
The rise of molecular HIV surveillance: Implications on consent and criminalization A McClelland, A Guta, M Gagnon Critical Public Health 30 (4), 487-493, 2020 | 50 | 2020 |
Power, discourse, and resistance: Poststructuralist influences in nursing D Holmes, M Gagnon Nursing Philosophy 19 (1), e12200, 2018 | 48 | 2018 |
Program development for enhancing adherence to antiretroviral therapy among persons living with HIV J Côté, G Godin, PR Garcia, M Gagnon, G Rouleau AIDS Patient Care and STDs 22 (12), 965-975, 2008 | 47 | 2008 |
A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone M Perri, N Kaminski, M Bonn, G Kolla, A Guta, AM Bayoumi, ... Harm reduction journal 18, 1-9, 2021 | 45 | 2021 |
Whistleblowing: A concept analysis M Gagnon, A Perron Nursing & health sciences 22 (2), 381-389, 2020 | 43 | 2020 |
HIV, viral suppression and new technologies of surveillance and control A Guta, SJ Murray, M Gagnon Body & Society 22 (2), 82-107, 2016 | 41 | 2016 |
Body–drug assemblages: theorizing the experience of side effects in the context of HIV treatment M Gagnon, D Holmes Nursing Philosophy 17 (4), 250-261, 2016 | 38 | 2016 |
Mapping HIV community viral load: Space, power and the government of bodies M Gagnon, A Guta Critical Public Health 22 (4), 471-483, 2012 | 35 | 2012 |
Corporate contact tracing as a pandemic response M French, A Guta, M Gagnon, E Mykhalovskiy, SL Roberts, S Goh, ... Critical Public Health 32 (1), 48-55, 2022 | 28 | 2022 |
It’s time to allow assisted injection in supervised injection sites M Gagnon CMAJ 189 (34), E1083-E1084, 2017 | 28 | 2017 |
Resisting the digital medicine panopticon: toward a bioethics of the oppressed A Guta, J Voronka, M Gagnon The American Journal of Bioethics 18 (9), 62-64, 2018 | 26 | 2018 |
From distress to illness: a critical analysis of medicalization and its effects in clinical practice JD Jacob, M Gagnon, J McCabe Journal of psychiatric and mental health nursing 21 (3), 257-263, 2014 | 25 | 2014 |
Treatment adherence redefined: a critical analysis of technotherapeutics M Gagnon, JD Jacob, A Guta Nursing Inquiry 20 (1), 60-70, 2013 | 25 | 2013 |